Simplex Trading, LLC Novartis Ag Transaction History

Simplex Trading, LLC

$2.81 Billion
Q3 2024

A detailed history of Simplex Trading, LLC transactions in Novartis Ag stock. As of the latest transaction made, Simplex Trading, LLC holds 1,113 shares of NVS stock, worth $108,050. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,113

Holding current value

$108,050

% of portfolio

0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$106.13 - $120.89 $118,122 - $134,550	1,113 New	1,113 $128,000
Q4 2023 Feb 02, 2024	BUY	$92.27 - $101.54 $1.45 Million - $1.6 Million	15,728 Added 175.24%	24,703 $2.49 Million
Q3 2023 Nov 01, 2023	BUY	$94.73 - $105.13 $850,201 - $943,541	8,975 New	8,975 $914,000
Q4 2022 Feb 02, 2023	BUY	$75.55 - $92.52 $3.79 Million - $4.64 Million	50,141 Added 82.25%	111,100 $10.1 Million
Q3 2022 Nov 04, 2022	BUY	$74.61 - $87.26 $2.7 Million - $3.16 Million	36,194 Added 146.15%	60,959 $4.63 Million
Q2 2022 Aug 03, 2022	SELL	$80.52 - $93.75 $2.99 Million - $3.49 Million	-37,194 Reduced 60.03%	24,765 $2.09 Million
Q1 2022 May 02, 2022	SELL	$80.11 - $90.62 $4.48 Million - $5.07 Million	-55,900 Reduced 47.43%	61,959 $5.44 Million
Q4 2021 Feb 23, 2022	BUY	$79.7 - $88.13 $9.04 Million - $9.99 Million	113,384 Added 2533.72%	117,859 $10.3 Million
Q2 2021 Aug 12, 2021	BUY	$85.24 - $94.15 $381,449 - $421,321	4,475 New	4,475 $408,000
Q1 2020 Apr 29, 2020	SELL	$70.67 - $99.01 $2.63 Million - $3.69 Million	-37,282 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$84.35 - $95.37 $3.14 Million - $3.56 Million	37,282 New	37,282 $3.53 Million

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $209B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account